00823nas a2200301   4500000000100000000000100001008004100002653001300043653002100056653001800077653004400095653001300139653002000152100001500172700001500187700001600202700002300218700001300241700001700254700001500271700001500286700001600301245012900317250001500446300002200461490000700483020003100490       2024                            d10aCovid-1910aadjuvent therapy10abreast cancer10aendocrine therapy < hormone therapy10apandemic10aProstate cancer1 aN. Barclay1 aM. Català1 aA. Jödicke1 aD. Prieto-Alhambra1 aD. Newby1 aA. Delmestri1 aW . Y. Man1 aSerrano À1 aM. Moncusí00aCollateral effects of the COVID-19 pandemic on endocrine treatments for breast and prostate cancer in the UK: a cohort study  a2024/06/04  a175883592412531150 v16  a1758-8340 (Print)1758-8340